Fund profile
Tickers
SBIO
Fund manager
Total assets
$83.72 mm
Liabilities
$33.05 k
Net assets
$83.69 mm
Number of holdings
107.00
SBIO stock data
107 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
IMVT Immunovant Inc | 3.61 mm | 92.30 k shares | 4.32 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 3.43 mm | 66.29 k shares | 4.10 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 2.88 mm | 111.25 k shares | 3.45 | Common equity | Long | Cayman Islands |
ALKS Alkermes plc | 2.84 mm | 117.65 k shares | 3.39 | Common equity | Long | Ireland |
ACAD Acadia Pharmaceuticals Inc | 2.58 mm | 115.65 k shares | 3.08 | Common equity | Long | USA |
INSM Insmed Inc | 2.54 mm | 101.58 k shares | 3.04 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 2.25 mm | 33.33 k shares | 2.69 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 2.23 mm | 202.81 k shares | 2.67 | Common equity | Long | USA |
KRYS Krystal Biotech Inc | 2.06 mm | 19.78 k shares | 2.46 | Common equity | Long | USA |
Zai Lab, Ltd.
|
1.90 mm | 69.74 k shares | 2.27 | Common equity | Long | Cayman Islands |
CORT Corcept Therapeutics Inc | 1.85 mm | 72.44 k shares | 2.20 | Common equity | Long | USA |
Immunocore Holdings PLC
|
1.82 mm | 34.57 k shares | 2.18 | Common equity | Long | UK |
DNLI Denali Therapeutics Inc | 1.80 mm | 97.07 k shares | 2.15 | Common equity | Long | USA |
ACLX Arcellx Inc | 1.79 mm | 34.16 k shares | 2.14 | Common equity | Long | USA |
GLPG Galapagos NV | 1.73 mm | 46.29 k shares | 2.07 | Common equity | Long | Belgium |
XENE Xenon Pharmaceuticals Inc | 1.66 mm | 45.31 k shares | 1.98 | Common equity | Long | Canada |
RYTM Rhythm Pharmaceuticals Inc. | 1.34 mm | 40.20 k shares | 1.61 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 1.34 mm | 44.20 k shares | 1.60 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 1.33 mm | 69.33 k shares | 1.58 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 1.28 mm | 40.65 k shares | 1.53 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 1.23 mm | 37.82 k shares | 1.47 | Common equity | Long | Ireland |
CRNX Crinetics Pharmaceuticals Inc | 1.23 mm | 38.63 k shares | 1.47 | Common equity | Long | USA |
VCEL Vericel Corp | 1.20 mm | 33.65 k shares | 1.43 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 1.09 mm | 110.21 k shares | 1.30 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals Inc | 1.09 mm | 75.29 k shares | 1.30 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 1.02 mm | 149.55 k shares | 1.22 | Common equity | Long | USA |
PNT POINT Biopharma Global Inc. | 1.02 mm | 74.71 k shares | 1.21 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 1.01 mm | 33.38 k shares | 1.20 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc | 1.00 mm | 492.83 k shares | 1.20 | Common equity | Long | USA |
VIR Vir Biotechnology Inc | 899.92 k | 94.83 k shares | 1.08 | Common equity | Long | USA |
IRON Disc Medicine Inc | 891.93 k | 16.16 k shares | 1.07 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc | 875.29 k | 101.31 k shares | 1.05 | Common equity | Long | Canada |
AGIO Agios Pharmaceuticals Inc | 875.28 k | 39.37 k shares | 1.05 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 863.48 k | 70.66 k shares | 1.03 | Common equity | Long | USA |
ARVN Arvinas Inc | 830.11 k | 37.78 k shares | 0.99 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 828.31 k | 42.30 k shares | 0.99 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 817.05 k | 49.09 k shares | 0.98 | Common equity | Long | USA |
MORF Morphic Holding Inc | 802.36 k | 33.86 k shares | 0.96 | Common equity | Long | USA |
KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares | 801.43 k | 49.56 k shares | 0.96 | Common equity | Long | Bermuda |
RCUS Arcus Biosciences Inc | 792.50 k | 52.62 k shares | 0.95 | Common equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 787.08 k | 133.86 k shares | 0.94 | Common equity | Long | USA |
XNCR Xencor Inc | 785.26 k | 42.82 k shares | 0.94 | Common equity | Long | USA |
VRNA Verona Pharma Plc | 759.01 k | 56.14 k shares | 0.91 | Common equity | Long | UK |
PTGX Protagonist Therapeutics Inc | 739.95 k | 40.63 k shares | 0.88 | Common equity | Long | USA |
GERN Geron Corp. | 713.52 k | 369.70 k shares | 0.85 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 711.37 k | 61.43 k shares | 0.85 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 702.06 k | 55.68 k shares | 0.84 | Common equity | Long | USA |
MNKD Mannkind Corp | 686.20 k | 189.56 k shares | 0.82 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 673.89 k | 47.59 k shares | 0.81 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 657.56 k | 39.28 k shares | 0.79 | Common equity | Long | USA |
MDXG Mimedx Group Inc | 637.25 k | 82.01 k shares | 0.76 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 635.87 k | 20.96 k shares | 0.76 | Common equity | Long | USA |
SAVA Cassava Sciences Inc | 617.53 k | 29.65 k shares | 0.74 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 587.06 k | 42.27 k shares | 0.70 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 561.11 k | 49.88 k shares | 0.67 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 525.06 k | 122.68 k shares | 0.63 | Common equity | Long | UK |
VRDN Viridian Therapeutics Inc | 516.40 k | 30.85 k shares | 0.62 | Common equity | Long | USA |
KURA Kura Oncology Inc | 507.09 k | 52.44 k shares | 0.61 | Common equity | Long | USA |
AMAM Ambrx Biopharma Inc. | 503.39 k | 43.62 k shares | 0.60 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 500.09 k | 39.72 k shares | 0.60 | Common equity | Long | USA |
REPL Replimune Group Inc | 465.88 k | 41.67 k shares | 0.56 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 449.69 k | 18.78 k shares | 0.54 | Common equity | Long | USA |
ETNB 89bio Inc | 428.66 k | 53.32 k shares | 0.51 | Common equity | Long | USA |
VERA Vera Therapeutics Inc - Ordinary Shares | 424.13 k | 31.30 k shares | 0.51 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corporation | 417.34 k | 57.88 k shares | 0.50 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 408.77 k | 52.34 k shares | 0.49 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 380.87 k | 23.04 k shares | 0.46 | Common equity | Long | USA |
HLVX HilleVax Inc | 379.77 k | 27.70 k shares | 0.45 | Common equity | Long | USA |
MGNX Macrogenics Inc | 359.24 k | 43.76 k shares | 0.43 | Common equity | Long | USA |
RAPT RAPT Therapeutics Inc | 352.41 k | 24.27 k shares | 0.42 | Common equity | Long | USA |
TVTX Travere Therapeutics Inc | 332.73 k | 52.98 k shares | 0.40 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals Inc | 326.08 k | 67.51 k shares | 0.39 | Common equity | Long | USA |
ALEC Alector Inc | 320.93 k | 59.21 k shares | 0.38 | Common equity | Long | USA |
AVTE Aerovate Therapeutics Inc | 306.78 k | 19.53 k shares | 0.37 | Common equity | Long | USA |
PROK ProKidney Corp - Ordinary Shares | 279.17 k | 166.17 k shares | 0.33 | Common equity | Long | Cayman Islands |
ALLO Allogene Therapeutics Inc | 278.26 k | 118.41 k shares | 0.33 | Common equity | Long | USA |
EWTX Edgewise Therapeutics Inc | 272.57 k | 44.83 k shares | 0.33 | Common equity | Long | USA |
ANAB AnaptysBio Inc | 265.20 k | 18.76 k shares | 0.32 | Common equity | Long | USA |
ITOS ITeos Therapeutics Inc | 236.61 k | 25.28 k shares | 0.28 | Common equity | Long | USA |
ALXO Alx Oncology Holdings Inc | 227.88 k | 29.07 k shares | 0.27 | Common equity | Long | USA |
AURA Aura Biosciences Inc | 216.36 k | 26.98 k shares | 0.26 | Common equity | Long | USA |
KALV KalVista Pharmaceuticals Inc | 204.25 k | 24.20 k shares | 0.24 | Common equity | Long | USA |
MLYS Mineralys Therapeutics Inc | 192.22 k | 28.86 k shares | 0.23 | Common equity | Long | USA |
TERN Terns Pharmaceuticals Inc | 191.96 k | 43.14 k shares | 0.23 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals Inc | 176.14 k | 58.91 k shares | 0.21 | Common equity | Long | USA |
VNDA Vanda Pharmaceuticals Inc | 151.13 k | 40.63 k shares | 0.18 | Common equity | Long | USA |
CMPX Compass Therapeutics Inc | 148.55 k | 90.03 k shares | 0.18 | Common equity | Long | USA |
MRSN Mersana Therapeutics Inc | 140.45 k | 85.12 k shares | 0.17 | Common equity | Long | USA |
ENTA Enanta Pharmaceuticals Inc | 138.90 k | 14.87 k shares | 0.17 | Common equity | Long | USA |
STOK Stoke Therapeutics Inc | 118.47 k | 31.26 k shares | 0.14 | Common equity | Long | USA |
ALT Altimmune Inc | 117.61 k | 37.22 k shares | 0.14 | Common equity | Long | USA |
PDSB PDS Biotechnology Corporation | 114.67 k | 21.80 k shares | 0.14 | Common equity | Long | USA |
ALDX Aldeyra Therapeutics Inc | 114.66 k | 41.39 k shares | 0.14 | Common equity | Long | USA |
AADI Aadi Bioscience Inc | 91.13 k | 17.33 k shares | 0.11 | Common equity | Long | USA |
IMAB I-Mab | 90.25 k | 57.85 k shares | 0.11 | Common equity | Long | Cayman Islands |
VTYX Ventyx Biosciences Inc | 89.85 k | 41.60 k shares | 0.11 | Common equity | Long | USA |
KPTI Karyopharm Therapeutics Inc | 62.20 k | 80.78 k shares | 0.07 | Common equity | Long | USA |
IFRX InflaRx N.V. | 56.16 k | 41.60 k shares | 0.07 | Common equity | Long | Netherlands |
ACRS Aclaris Therapeutics Inc | 43.74 k | 50.01 k shares | 0.05 | Common equity | Long | USA |
KZR Kezar Life Sciences Inc | 43.01 k | 51.35 k shares | 0.05 | Common equity | Long | USA |
State Street Institutional Treasury Plus Money Market Fund | 30.22 k | 30.22 k shares | 0.04 | Short-term investment vehicle | Long | USA |
Azn Ln - Cvr | 0.04 | 29.05 k contracts | 0.00 | Equity derivative | N/A | UK |
Radius Health CVR | 0.03 | 28.64 k contracts | 0.00 | Equity derivative | N/A | USA |
Chinook Therapeutics, Inc. | 0.02 | 20.70 k contracts | 0.00 | Equity derivative | N/A | USA |
OABI OmniAb Inc | 0 | 3.65 k contracts | 0.00 | Equity derivative | N/A | USA |
OABI OmniAb Inc | 0 | 3.65 k contracts | 0.00 | Equity derivative | N/A | USA |
State Street Navigator Securities Lending Government Money Market Portfolio | 0 | 0.00 shares | 0.00 | Short-term investment vehicle | Long | USA |